TALLAHASSEE, Fla. - Tallahassee Memorial HealthCare (TMH) has successfully completed its 200th case using the CathWorks FFRangio® System, an artificial intelligence (AI)-powered technology that enhances the assessment of coronary artery disease during cardiac catheterization. TMH was the first hospital in Florida to adopt this advanced technology, further establishing its leadership in cutting-edge cardiovascular innovation.

The FFRangio® System uses artificial intelligence and advanced computational modeling to analyze routine coronary angiograms and create a patient-specific 3D model of the coronary arteries. The system then calculates fractional flow reserve (FFR) - the gold standard for determining whether a coronary blockage is restricting blood flow - without requiring invasive pressure wires or medications to artificially stress the heart.

Traditionally, FFR measurement requires inserting a specialized pressure wire into the artery and administering drugs to simulate hyperemia. With FFRangio®, TMH's interventional cardiologists can obtain physiologic data directly from standard angiographic images already captured during the procedure. This approach supports more efficient, wire-free functional assessment while maintaining diagnostic precision.

"Reaching our 200th FFRangio case reflects our commitment to delivering advanced, evidence-based cardiovascular care to the patients we serve," said Chris Buzzard, Director of Interventional Cardiology. "By integrating AI-driven physiologic assessment into the cath lab, we are able to make more informed treatment decisions in real time and tailor interventions to each individual patient."

Coronary artery disease remains a leading cause of death in the United States. Accurate assessment of whether a blockage is truly limiting blood flow is critical in determining whether a patient will benefit from stenting or can be managed with medication alone. The addition of FFRangio® technology enhances TMH's ability to provide precise, patient-centered heart care.

TMH continues to invest in innovative cardiovascular technologies that support improved outcomes, enhanced patient safety and physician excellence. As a regional leader in heart and vascular care, TMH offers comprehensive services ranging from diagnostic cardiac catheterization to advanced interventional procedures, structural heart therapies and cardiac imaging.

Learn more about our heart and vascular program at TMH.ORG/Heart.